Clinical decision support, provider-facing analysis, and bedside-relevant reporting.
The Quiet Dismantling — a A patient at twenty-nine weeks. Severe-range pressures. Vessels clamped down so hard no line will go in. And the one drug whose entire point was that it could be reached anywhere in the world — not in the building.
Medication shortages widen from the L&D code cart to the full women
Obstetric medication shortages — rolling stockouts of the generic drugs that keep women alive during childbirth. The supply chain is not broken; it is politically compromised.
A thirty-five-week pregnant patient. Three problems. One coverage window that has to hold for a year. What postpartum Medicaid coverage loss looks like from the exam room.
Three corporate boards. Roughly forty-two percent of all U.S. prescription dispensing revenue. The dispensing decisions of the American retail pharmacy system are being made for legal exposure, not clinical need.
116 rural L&D closures. AAMC residency-application gap by state. NHSC, J-1 waivers, Title VII and VIII workforce funding. The named tools that exist to rebuild what has been dismantled.
The only federal program dedicated to contraception and cancer screening for millions of low-income women is being defunded administratively — without a Congressional vote. The new evidence, the clinical cost, and the countdown to the FY…
Conscience clauses, pharmacy refusals, and the federal backstop that was quietly removed in January 2026. The last mile of medical care is now controlled by someone who never examined the patient.
Cards link to the original — every piece is published on laboracollective.com or one of our Labora Collective series sites.
Goes to Dr. Connor and the team, with the page you are on.